The Role of 4G allele in Plasminogen Activator Inhibitor type-1 rs1799889 Gene as Biomarker to Thrombophilic Complication among Type 2 Diabetic Patients
Zhao L, Huang P. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk. Int J Clin Exp Med. 2013;6(8):632-40
Ibrahim RE, Ibrahim SEH, Abdalsamea K, Haj-Alzebar AB, Babiker AM, Nour BYM. Evaluation of Common Coagulation Tests in Type2 Diabetic Patients and Association with Diabetic Pre-cardiovascular Complications, Gezira State-Sudan, 2020-2021. Asian Hematology Research Journal. 2021;5(4):1-6.
Almakey EA, Makeen AM, Saeed OK, Mohamedahmed KA. Association between Adiponectin and Insulin Resistance among Sudanese Males with Type 2 Diabetes Mellitus. Chinese J Med Res. 2021;4(2):34-7.
Saboor M, Moinuddin M, Ilyas S. Comparison of Platelet CD Markers between Normal Individuals and Untreated Patients with Type 2 Diabetes Mellitus. J Hematol Thromb Dis. 2013;2:123.
Khalaf FA, Ibrahim HR, Bedair HM, Allam MM, Elshormilisy AA, Ali ST, Gaber WM. Plasminogen activator inhibitor-1 gene polymorphism as a risk factor for vascular complications in type 2 diabetes mellitus. Egypt J Med Hum Genet. 2019;20:18.
Aburto-Mejía E, Santiago-Germán D, Martínez-Marino M, Galván-Plata ME, Almeida-Gutiérrez E, López-Alarcón M, et al. Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease. BioMed Res Int. 2017;2017(2):6519704.
Eriksson P, Kallin B, Van 't Hooft FM, Båvenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A. 1995;92(6):1851-5.
Chevilley A, Lesept F, Lenoir S, Ali C, Parcq J, Vivien D. Impacts of tissue-type plasminogen activator (tPA) on neuronal survival. Front Cell Neurosci. 2015;16(9):415.
Parpugga TK, Tatarunas V, Skipskis V, Kupstyte N, Zaliaduonyte-Peksiene D, Lesauskaite V. The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction. Dis Markers. 2015;2015:260101.
Nordt TK, Lohrmann J, Bode C. Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis. Thromb Res. 2001;103(Suppl 1):S1-5.
Copyright (c) 2022 Galen Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).